A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics

Schizophrenia Research
Mary Weber, Kathleen Wyne

Abstract

Obesity and diabetes have caused problems for individuals with schizophrenia long before atypical antipsychotic agents. The prevalence of obesity, insulin resistance, impaired glucose tolerance, type 2 diabetes mellitus, dyslipidemia, and the Metabolic Syndrome has increased in people with schizophrenia as compared to the general population. Risk reduction studies for persons with obesity, diabetes, and cardiovascular disease indicate that cognitive/behavioral interventions that promote motivation and provide strategies to overcome the barriers in adherence to diet and activity modification are effective interventions for weight management and risk reduction. In the landmark multi-center randomized-controlled trial study, the Diabetes Prevention Project (DPP), a cognitive/behavioral intervention, was more successful in producing weight loss and preventing diabetes than the drugs metformin, troglitazone or placebo. This pilot study examined the effectiveness of a cognitive/behavioral group intervention, modified after the DPP program, in individuals with schizophrenia or schizoaffective disorder taking atypical antipsychotics in a large urban public mental health system. Outcome measures included body weight, body mass index, wa...Continue Reading

Citations

Mar 21, 2012·The Journal of Behavioral Health Services & Research·Noosha NivAlexander S Young
Aug 2, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Mario Alvarez-JiménezPatrick D McGorry
Jun 2, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Alex J Mitchell, David Lawrence
Oct 15, 2008·Current Opinion in Psychiatry·Jonathan M AmielJohn W Newcomer
Dec 4, 2009·Schizophrenia Bulletin·Lisa B DixonUNKNOWN Schizophrenia Patient Outcomes Research Team (PORT)
Aug 3, 2010·Psychiatric Services : a Journal of the American Psychiatric Association·Leopoldo J CabassaRoberto Lewis-Fernández
Nov 3, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·G L DaumitL J Appel
Jan 5, 2011·Biological Research for Nursing·Kimberly R WarrenDeanna L Kelly
Apr 13, 2011·The International Journal of Behavioral Nutrition and Physical Activity·Nick VerhaegheLieven Annemans
Jun 24, 2006·Wiener klinische Wochenschrift·Julia EnglChristoph Ebenbichler
Jul 1, 2010·Expert Review of Neurotherapeutics·Lawrence Maayan, Christoph U Correll
Mar 13, 2010·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Maria A Cerdá EsteveJuan F Cano
Sep 30, 2010·Journal of Psychosocial Nursing and Mental Health Services·Mary Weber
Mar 17, 2009·American Journal of Preventive Medicine·David B AllisonJonathan E Alpert
Aug 28, 2007·The Psychiatric Clinics of North America·Deanna L KellyRobert R Conley
Apr 25, 2009·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·J M GabrieleR R Reeves
Apr 2, 2009·Journal of Evaluation in Clinical Practice·Amanda JonesSeetal Dodd
Jan 22, 2009·Perspectives in Psychiatric Care·Mary WeberMina Mohammadi
Jan 13, 2009·Acta Psychiatrica Scandinavica·J M Meyer, S M Stahl
Jul 14, 2007·International Journal of Clinical Practice·A TschonerC F Ebenbichler
Feb 22, 2011·The Psychiatric Clinics of North America·Rohan Ganguli, Martin Strassnig
Mar 31, 2016·Intellectual and Developmental Disabilities·DeLawnia Comer-HaGansZo Ramamonjiarivelo
Jan 16, 2008·Psychiatric Rehabilitation Journal·Yuval MelamedAvi Bleich
Dec 24, 2014·Community Mental Health Journal·Nancy E CarsonRuth Saunders
Nov 5, 2016·The British Journal of Psychiatry : the Journal of Mental Science·Scott B TeasdaleBrendon Stubbs
Mar 17, 2017·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Laura R MagniRoberta Rossi
Jun 20, 2017·JBI Database of Systematic Reviews and Implementation Reports·Doreen W MucheruLesley MacDonald-Wicks
Jan 1, 2009·International Journal of Psychiatry in Clinical Practice·Tina Veit, Christian Barnas
Jan 1, 2008·Journal of the American Psychiatric Nurses Association·Mary WeberMonica Nelson
Nov 28, 2012·Therapeutic Advances in Endocrinology and Metabolism·Evangelos Papanastasiou
Jan 19, 2010·Journal of Psychopharmacology·Linda Björkhem-BergmanJonatan D Lindh
Mar 24, 2016·The Cochrane Database of Systematic Reviews·Robert PearsallJohn Geddes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Related Papers

Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing
Kimberly H LittrellCraig G Johnson
© 2021 Meta ULC. All rights reserved